Medtronic (MDT) Cash from Financing Activities (2014 - 2026)

Medtronic's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at -$2.1 billion for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 19.05% year-over-year to -$2.1 billion; the TTM figure through Jan 2026 stood at -$5.2 billion (up 3.18% YoY), while the FY2025 annual figure was -$4.4 billion, up 2.0% from the prior year.
• Cash from Financing Activities came in at -$2.1 billion for Q1 2026 at Medtronic, down from -$395.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $3.0 billion in Q4 2022 to a low of -$4.9 billion in Q2 2023.
• A 5-year average of -$1.2 billion and a median of -$1.3 billion in 2025 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities surged 360.95% in 2022 and slumped 493.33% in 2024, its largest moves.
• Medtronic's Cash from Financing Activities stood at $3.0 billion in 2022, then plunged by 102.99% to -$90.0 million in 2023, then plunged by 493.33% to -$534.0 million in 2024, then climbed by 26.03% to -$395.0 million in 2025, then slumped by 428.35% to -$2.1 billion in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$2.1 billion, -$395.0 million, and -$1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison